Policy and Design Considerations for Most-Favored-Nation Drug Pricing
0 citations
Abstract
This Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.
// Source
Authors: Matthew Vogel, Olivier J. Wouters
Institutions: Harvard University, Brown University